Schedule 13D ownership disclosure

N/A

Security class unavailable · CUSIP: 01345P106

Event date: 2019-10-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
566,381
Percent of class
4.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000903423-19-000329
Form type
SC 13D/A
Filer
ALBIREO PHARMA, INC.
CIK
CIK 1322505
Filed
Oct 30, 2019
Reporting period
Oct 28, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub